Putting Patients First
A Closer Look at RA Treatment: Treat-to-Target Using Shared Decision-Making

Released: December 11, 2020

Expiration: December 10, 2021

Stanley B. Cohen
Stanley B. Cohen, MD
Sheetal Desai
Sheetal Desai, MD, MSEd
Eric M. Ruderman
Eric M. Ruderman, MD

Activity

Progress
1
Course Completed

In this episode, Dr. Stanley Cohen, Dr. Sheetal Desai, and Dr. Eric Ruderman discuss how to translate information on JAK inhibitors and other treatments for your patient population in the clinic, covering practical tips on using:

  • Treat-to-target approaches
  • Disease activity measures
  • Shared decision-making
  • Decision aids
  • Translating clinical trial evidence

Also included are the experts’ answers to questions from clinicians like you.

Stanley B. Cohen, MD
Clinical Professor
Department of Internal Medicine
University of Texas Southwestern Medical School
Co-Director
Division of Rheumatology
Presbyterian Hospital
Co-Medical Director
Metroplex Clinical Research Center
Dallas, Texas  

Sheetal Desai, MD, MSEd
Chief of Rheumatology
Program Director
University of California, Irvine
Irvine, California

Eric M. Ruderman, MD
Professor, Associate Chief
Division of Rheumatology
Northwestern University Feinberg School of Medicine
Clinical Practice Director
Northwestern Medical Group
Chicago, Illinois